![Mark Kerslake](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Kerslake
Director/Board Member at Recros Medica, Inc.
Profile
Mark Kerslake is currently a Director at Recros Medica, Inc. He holds an MBA from the University of California, Los Angeles.
Mark Kerslake active positions
Companies | Position | Start |
---|---|---|
Recros Medica, Inc.
![]() Recros Medica, Inc. Medical SpecialtiesHealth Technology Recros Medica, Inc. is a clinical stage medical device company, which engages in the research and development of aesthetic products to enhance appearance. Its product called Nuvellus Focal Contouring System is use by dermatologists, plastic surgeons, and other aesthetic physicians to reduce skin laxity, enhance focal aesthetic contouring, and provide a natural alternative to commercial dermal fillers. The company was founded by Edward Knowlton, David F. Hale, and Cathy L. McCarthy in 2014 and is headquartered in San Diego, CA. | Director/Board Member | 03/01/2018 |
Training of Mark Kerslake
University of California, Los Angeles | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Recros Medica, Inc.
![]() Recros Medica, Inc. Medical SpecialtiesHealth Technology Recros Medica, Inc. is a clinical stage medical device company, which engages in the research and development of aesthetic products to enhance appearance. Its product called Nuvellus Focal Contouring System is use by dermatologists, plastic surgeons, and other aesthetic physicians to reduce skin laxity, enhance focal aesthetic contouring, and provide a natural alternative to commercial dermal fillers. The company was founded by Edward Knowlton, David F. Hale, and Cathy L. McCarthy in 2014 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Mark Kerslake